Investment
Features
FeesSafety
Academy
More
Pluang+

Compare dYdX (DYDX) vs Enzyme (MLN) Price & Performance

Price performance (Past 24H)

Key statistics

dYdX vs Enzyme — how do they compare? dYdX trades at Rp1,956 (market cap Rp1,66T, Rp37,16M 24h volume), while Enzyme trades at Rp30,212 (market cap Rp134,13M, Rp104,56M 24h volume). The key difference: dYdX is far larger — about 12376.1× Enzyme's market cap, and dYdX's supply is capped (848,6M / 1B DYDX (85%)) while Enzyme's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold dYdX for 56 Days and Enzyme for 29 Days on average.

DYDXMLN
Market Cap
Rp1,66TRp134,13M
Volume (24h)
Rp37,16MRp104,56M
Circulating Supply
848,6M / 1B DYDX (85%)3,3M MLN
Typical Hold Time
56 Days29 Days

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

dYdX

DYDX is currently trading at Rp1,968.47 with a market cap of Rp1.67T, showing bearish technical signals with 18 sell signals versus 4 buy signals. The token is near its pivot point of Rp1,966 with immediate support at Rp1,943 and resistance at Rp1,989. With 85% of the 1 million max supply in circulation and average hold time of 56 days, the token shows moderate distribution.

Overall outlook remains cautious due to bearish technical momentum, though RSI_6 at 28.95 suggests potential oversold conditions. Key risks include high volatility and regulatory uncertainty, while opportunities exist if the protocol maintains its decentralized exchange leadership. Investors should monitor trading volume patterns and ecosystem developments closely.

Enzyme

Enzyme (MLN) shows limited market activity with a modest market cap of Rp134,13M and circulating supply of 3,3jt tokens. The asset demonstrates relatively low volatility with an average hold time of 29 days, suggesting stable holder behavior. Trading volumes appear subdued across exchanges, indicating limited speculative interest. No significant protocol upgrades or ecosystem developments have been reported recently, though the project continues to operate its decentralized asset management platform.

Overall outlook remains cautious due to limited liquidity and trading activity. Key opportunities include potential ecosystem growth in decentralized finance asset management, while major risks include low market depth, regulatory uncertainty for DeFi protocols, and competition from larger DeFi platforms. The token's utility within its native protocol remains its primary value driver.

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

DYDX
36% Buy64% Sell
Avg holding period · 56 Days
MLN

No sentiment data available yet.

About dYdX

DYDX (dYdX) is the governance token for the layer 2 protocol of the eponymous non-custodial decentralized cryptocurrency exchange. An open-source platform with smart contract functionality, dYdX is designed for users to lend, borrow and trade crypto assets. Although dYdX supports spot trading, the main focus of the platform is on derivatives and margin trading.

Read more on DYDX

About Enzyme

Enzyme is an easy-to-use on-chain asset management system that enables access to digital assets and DeFi from one simple, unified app. It provides a front-to-back execution and order management system, which provides fully automated reporting, risk management, administration, governance and operations.

Read more on MLN